Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D‐QSAR Coupled to Scaffold‐Hopping Analysis

@article{Floresta2018IdentificationOP,
  title={Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D‐QSAR Coupled to Scaffold‐Hopping Analysis},
  author={Giuseppe Floresta and E. Amata and Maria Dichiara and A. Marrazzo and L. Salerno and G. Romeo and O. Prezzavento and V. Pittal{\`a} and A. Rescifina},
  journal={ChemMedChem},
  year={2018},
  volume={13}
}
A 3D quantitative structure–activity relationship (3D‐QSAR) model for predicting the activity of heme oxygenase 1 (HO‐1) inhibitors was constructed with the aim of providing a useful tool for the identification, design, and optimization of novel HO‐1 inhibitors. The model was built using a set of 222 HO‐1 inhibitors recovered from the Heme Oxygenase Database (HemeOxDB) and developed with the software Forge. The present model showed high statistical quality, as confirmed by its robust predictive… Expand
View on Wiley
ncbi.nlm.nih.gov
22 Citations
Background Citations
1
Methods Citations
4

22 Citations

Citation Type

Citation Type

Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis †
  • 15
  • PDF
Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis.
  • 17
Fourfold Filtered Statistical/Computational Approach for the Identification of Imidazole Compounds as HO-1 Inhibitors from Natural Products
  • 9
  • PDF
3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation.
  • 15
  • PDF
FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets
  • 7
Structure-Based Approach for the Prediction of Mu-opioid Binding Affinity of Unclassified Designer Fentanyl-Like Molecules
  • 4
  • PDF
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region.
iVS analysis to evaluate the impact of scaffold diversity in the binding to cellular targets relevant in cancer
  • 2
  • PDF
In silico studies of novel scaffold of thiazolidin-4-one derivatives as anti-Toxoplasma gondii agents by 2D/3D-QSAR, molecular docking, and molecular dynamics simulations
  • 1
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors.
  • 15
...
1
2
3
...

References

SHOWING 1-10 OF 55 REFERENCES
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors
  • 26
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands.
  • 26
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors
  • 26
A Novel, “Double-Clamp” Binding Mode for Human Heme Oxygenase-1 Inhibition
  • 18
  • PDF
Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds
  • 27
  • PDF
Development of a Sigma‐2 Receptor affinity filter through a Monte Carlo based QSAR analysis
  • A. Rescifina, Giuseppe Floresta, +5 authors E. Amata
  • Chemistry, Medicine
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2017
  • 41
3D-QSAR and 3D-QSSR studies of thieno[2,3-d]pyrimidin-4-yl hydrazone analogues as CDK4 inhibitors by CoMFA analysis
  • 16
  • PDF
Development of Small-Molecule Cryptochrome Stabilizer Derivatives as Modulators of the Circadian Clock
  • 26
In silico-driven multicomponent synthesis of 4,5- and 1,5-disubstituted imidazoles as indoleamine 2,3-dioxygenase inhibitors
  • 13
  • PDF
X-ray crystal structure of human heme oxygenase-1 in complex with 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone: a common binding mode for imidazole-based heme oxygenase-1 inhibitors.
  • 44
  • PDF
...
1
2
3
4
5
...